1.
Bone Joint J
; 98-B(7): 892-900, 2016 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27365466
RESUMO
Joint replacement of the hip and knee remain very satisfactory operations. They are, however, expensive. The actual manufacturing of the implant represents only 30% of the final cost, while sales and marketing represent 40%. Recently, the patents on many well established and successful implants have expired. Companies have started producing and distributing implants that purport to replicate existing implants with good long-term results. The aims of this paper are to assess the legality, the monitoring and cost saving implications of such generic implants. We also assess how this might affect the traditional orthopaedic implant companies. Cite this article: Bone Joint J 2016;98-B:892-900.
Assuntos
Prótese de Quadril/economia , Prótese do Joelho/economia , Legislação de Dispositivos Médicos , Desenho de Prótese , Artroplastia de Quadril , Artroplastia do Joelho , Redução de Custos , Europa (Continente) , Humanos , Patentes como Assunto , Estados Unidos
2.
Ann R Coll Surg Engl
; 89(5): 530-2, 2007 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18172940